Higher Prescription Opioid Dose is Associated With Worse Patient-Reported Pain Outcomes and More Health Care Utilization
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Some prior research has examined pain-related variables based on prescription opioid dose, but data from studies involving patient-reported outcomes have been limited. This study examined the relationships between prescription opioid dose and self-reported pain intensity, function, quality of life, and mental health. Participants were recruited from two large integrated health systems, Kaiser Permanente Northwest (n=331) and VA Portland Health Care System (n=186). To be included, participants had to have musculoskeletal pain diagnoses and be receiving stable doses of long-term opioid therapy (LTOT). We divided participants into three groups based on current prescription opioid dose in daily morphine equivalent doses (MED): Low Dose (5 – 20 mg MED), Moderate Dose (20.1 – 50 mg MED), and Higher Dose (50.1 – 120 mg MED) groups. A statistically significant trend emerged where higher prescription opioid dose was associated with moderately-sized effects including greater pain intensity, more impairments in functioning and quality of life, poorer self-efficacy for managing pain, greater fear avoidance, and more healthcare utilization. Rates of potential alcohol and substance use disorders also differed among groups. Findings from this evaluation reveal significant differences in pain-related and substance-related factors based on prescription opioid dose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Bush, K. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1789 · Cited by 6,196
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898 · cited 1×
“The Patient Health Questionnaire (PHQ) was used to assess depressive symptoms.(30) The PHQ is a brief, reliable, and psychometrically valid measure used to screen for depressive symptoms.”
MethodCDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741 · cited 1×
“The Generalized Anxiety Disorder-7 Scale is a brief self-report measure designed to assess the severity of anxiety symptoms, and has been validated as a robust predictor of the different anxiety disorders.(28,44) The 3-item AUDIT-C(8) was used to screen for current alcohol use disorder.”
MethodNew Effect Size Rules of Thumb
Sawilowsky, S. S. (2009) · Journal of Modern Applied Statistical Methods · doi:10.22237/jmasm/1257035100 · Cited by 3,254
Waddell, G., Newton, M., Henderson, I., Somerville, D., & Main, C. J. (1993) · Pain · doi:10.1016/0304-3959(93)90127-b · Cited by 3,167
Skinner, H. A. (1982) · Addictive Behaviors · doi:10.1016/0306-4603(82)90005-3 · Cited by 3,134
Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain
Chou, R., Fanciullo, G. J., Fine, P. G., Adler, J. A., Ballantyne, J. C., Davies, P., Donovan, M. I., Fishbain, D. A., Foley, K. M., Fudin, J., et al. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2008.10.008 · Cited by 2,192
The pain self-efficacy questionnaire: Taking pain into account
Nicholas, M. K. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2005.12.008 · Cited by 1,656 · cited 2×
“The Pain SelfEfficacy Questionnaire is a 10-item test designed to assess perceived self-efficacy to cope with chronic pain.(36) The Fear-Avoidance Beliefs Questionnaire is a 16-item self-report measure;(49) we administered the 5-item subscale querying beliefs about physical activity.”
BackgroundMethodChou, R., Turner, J. A., Devine, E. B., Hansen, R. N., Sullivan, S. D., Blazina, I., Dana, T., Bougatsos, C., & Deyo, R. A. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2559 · Cited by 1,606
Self-citationAssociation Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
Bohnert, A. S. B. (2011) · JAMA · doi:10.1001/jama.2011.370 · Cited by 1,509
Persistent Pain and Well-being: A World Health Organization Study in Primary Care
Gureje, O., Von Korff, M., Simon, G. E., & Gater, R. (1998) · JAMA · doi:10.1001/jama.280.2.147 · Cited by 1,496 · cited 1×
“Musculoskeletal pain diagnoses were chosen because they comprise the majority of chronic pain conditions.(21) Participants must also have received a stable dose of at least 90 consecutive days of opioid therapy.”
BackgroundOpioids in chronic non-cancer pain: systematic review of efficacy and safety
Kalso, E., Edwards, J. E., Moore, A. R., & McQuay, H. J. (2004) · Pain · doi:10.1016/j.pain.2004.09.019 · Cited by 1,216 · cited 1×
“Concerns exist about the safety and misuse of opioid medications generally, as they are associated with side effects and adverse events, including constipation, fatigue, nausea, dizziness, vomiting, purposeful abuse, and diversion.(3,19,25) Relative to other analgesics, opioids carry increased likelihood of cardiovasc…”
BackgroundPsychological aspects of persistent pain: Current state of the science
Keefe, F. J., Rumble, M. E., Scipio, C. D., Giordano, L. A., & Perri, L. M. (2004) · The Journal of Pain · doi:10.1016/j.jpain.2004.02.576 · Cited by 954 · cited 1×
“Prior research demonstrates that pain self-efficacy, fear avoidance beliefs, and pain catastrophizing are robust predictors of treatment outcome.(24,26,37,46) The results from our larger prospective cohort analysis will examine the extent to which these variables are predictive of, and able to identify outcomes follow…”
BackgroundOpioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects
Furlan, A. D. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.051528 · Cited by 873
Turner, J. A., Holtzman, S., & Mancl, L. (2007) · Pain · doi:10.1016/j.pain.2006.09.005 · Cited by 530 · cited 1×
“Prior research demonstrates that pain self-efficacy, fear avoidance beliefs, and pain catastrophizing are robust predictors of treatment outcome.(24,26,37,46) The results from our larger prospective cohort analysis will examine the extent to which these variables are predictive of, and able to identify outcomes follow…”
BackgroundJensen, M. P., Turner, J. A., & Romano, J. M. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.4.655 · Cited by 473
Bohnert, A. S. B., Bonar, E. E., Cunningham, R., Greenwald, M. K., Thomas, L., Chermack, S., Blow, F. C., & Walton, M. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.018 · Cited by 123
Correlates of Higher-Dose Opioid Medication Use for Low Back Pain in Primary Care
Kobus, A. M., Smith, D. H., Morasco, B. J., Johnson, E. S., Yang, X., Petrik, A. F., & Deyo, R. A. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2012.09.003 · Cited by 97
Self-citation
Cited by
Witkiewitz, K., & Vowles, K. E. (2018) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13594 · Cited by 248
“…interesting that a concordant pattern of findings is present for opioids and benzodiazepines—higher doses of opioids and taking benzodiazepines are associated with greater pain intensity and interference among patients with pain (Kobus et al., 2012; Morasco et al., 2011, 2017; Seal et al., 2012).”
Pain Trends Among American Adults, 2002–2018: Patterns, Disparities, and Correlates
Zajacova, A., Grol-Prokopczyk, H., & Zimmer, Z. (2021) · Demography · doi:10.1215/00703370-8977691 · Cited by 224
Gardiner, P., Luo, M., D’Amico, S., Gergen-Barnett, K., White, L. F., Saper, R., Mitchell, S., & Liebschutz, J. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225540 · Cited by 55
Metadata
- Authors
- Morasco, B. J., Yarborough, B. J., Smith, N. X., Dobscha, S. K., Deyo, R. A., Perrin, N. A., & Green, C. A.
- Venue
- The Journal of Pain
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 18
- Issue
- 4
- Pages
- 437-445
- ISSN
- 1526-5900 (ISSN-L)
- OpenAlex
- W2563263703
- Cited by
- 82
- References
- 20
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.